South Dakota Investment Council - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.

Quarter-by-quarter ownership
South Dakota Investment Council ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,271,000
+30.5%
53,6030.0%0.06%
+9.1%
Q3 2020$2,506,000
-8.7%
53,603
-1.0%
0.06%
-14.1%
Q2 2020$2,746,000
-4.0%
54,123
-15.6%
0.06%
-17.9%
Q1 2020$2,861,000
-7.2%
64,123
-0.1%
0.08%
+21.9%
Q4 2019$3,084,000
+4.0%
64,210
-26.7%
0.06%
+10.3%
Q3 2019$2,964,000
+13.2%
87,650
+50.6%
0.06%
+7.4%
Q2 2019$2,619,000
+9.6%
58,200
-8.3%
0.05%
+5.9%
Q1 2019$2,390,000
-49.9%
63,500
-45.9%
0.05%
-8.9%
Q4 2018$4,774,000
+73.0%
117,400
+100.0%
0.06%
-6.7%
Q3 2018$2,759,000
+5.5%
58,700
-24.3%
0.06%
+5.3%
Q2 2018$2,614,000
+7.2%
77,500
-14.0%
0.06%
+1.8%
Q1 2018$2,438,000
-3.4%
90,100
-40.4%
0.06%0.0%
Q4 2017$2,524,000
-20.1%
151,300
-4.1%
0.06%
-12.5%
Q3 2017$3,158,000
-5.0%
157,800
-13.0%
0.06%
-8.6%
Q2 2017$3,325,000
+86.3%
181,4110.0%0.07%
+94.4%
Q1 2017$1,785,000
-9.8%
181,4110.0%0.04%
-14.3%
Q4 2016$1,979,000
-28.9%
181,411
-8.7%
0.04%
-27.6%
Q3 2016$2,785,000
+99.5%
198,8000.0%0.06%
+87.1%
Q2 2016$1,396,000
+9.1%
198,8000.0%0.03%
+10.7%
Q1 2016$1,280,000
-40.3%
198,800
+200.3%
0.03%
-40.4%
Q4 2015$2,145,00066,2080.05%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
AXON CAPITAL LP 216,200$9,729,00020.31%
GREAT POINT PARTNERS LLC 1,974,385$88,847,000,0009.86%
RTW INVESTMENTS, LP 3,137,361$141,181,0007.54%
Asymmetry Capital Management, L.P. 280,542$12,624,0006.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 259,000$11,642,0004.32%
Boxer Capital, LLC 1,000,000$45,000,0003.87%
Opaleye Management Inc. 226,388$10,187,0003.10%
SECTORAL ASSET MANAGEMENT INC 450,638$20,279,0002.42%
SCOPIA CAPITAL MANAGEMENT LP 983,005$44,235,0001.96%
Chubb Ltd 8,180$368,0001.82%
View complete list of PTC THERAPEUTICS INC shareholders